参考文献/References:
[1] 孙 炜,田小平,庄惠芹,等.肺癌患者血清HE4表达临床意义的初步探讨[J].现代检验医学杂志,2013,28(6):50-51,54.
Sun W,Tian XP,Zhuang HQ,et,al.Preliminary study of the clinicalsignificance of serum human epididymis protein 4(HE4)in patients with lung cancer[J].Journal of Modern Laboratory Medicine,2013,28(6):50-51,54.
[2] Bednarek AK,Laflin KJ,Daniel RL,et al.WWOX,a novel WW domain-containing protein mapping to human chromosome 16q23.3-24.1,a region frequently affected in breast cancer[J].Cancer Res,2000,60(8):2140-2145.
[3] Chang NS,Pratt N,Heath J,et al.Hyaluronidase induction of a WW domain-containing oxidoreductase that enhances tumor necrosis factor cytotoxicity[J].J Biol Chem,2001,276(5):3361-3370.
[4] 陈 晓,杨春鹿,赵 君,等.非小细胞肺癌组织中Livin和Smac蛋白表达及其临床意义的研究[J].中华肿瘤防治杂志,2008,15(12):905-909.
Chen X,Yang CL,Zhao J,et al.Study on expressions of Livin and Smac proteins in non-small cell lung cancer and their clinical significance[J].Chinese Journal of Cancer Prevention and Treatent,2008,15(12):905-909.
[5] 张 洁,李雅莉,刘 云,等.非小细胞肺癌中WWOX蛋白的表达及意义[J].国际呼吸杂志,2012,32(15):1125-1128,封3.
Zhang J,Li YL,Liu Y,et al.Expression of WWOX protein in non-small cell lung cancer and its significance[J].International Journal of Respiration,2012,32(15):1125-1128,封3.
[6] 闫海军,陈明伟.Bcl-2在肺癌中的表达及意义[J].临床肺科杂志,2013,18(1):14-15.
Yan HJ,Chen MW.Expression of Bcl-2 and its clinical significancein patients with lung cancer[J].Journal of Clinical Pulmonary Medicine,2013,18(1):14-15.
[7] 张黎黎,张 洁,张 林,等.p53,bcl-2,caspase-3在非小细胞肺癌组织中的表达及相关性分析[J].天津医药,2014,42(7):670-673.
Zhang LL,Zhang J,Zhang L,et al.Correlation analysis between expressions of p53,bcl-2 and caspase-3 in patients with non-small cell lung cancer[J].Tianjin Medical Journal,2014,42(7):670-673.
[8] Norrmen C,Suter U.AKT/mTOR signaling in myelination[J].Biochen SocTrans,2013,41(4):944-950.
[9] Chen T,Sahin A,Aldaz CM.Deletion map of chromosome 16q in ductal carcinoma in situ of the breast: refining a putative tumor suppressor gene region[J].Cancer Res,1996,56(24):5605-5609.
[10] Saluda-Gorgul A,Seta K,Nowakowska M,et al.W-WOX oxidoreduc tase-substrate and enzymatic characterization[J].Z Naturforsch,2011,66(1/2):73-82.
[11] Chang NS,Hsu LJ.Lin YS,et al.WW domain-containing oxidoreductase:acandidate tumor suppressor[J].Trends Mol Med,2007,13(1):12-22.
[12] Gaudio E,Palamarchuk A,Palumbo T,et al.Physical associationwith WWOX suppresses c-Jun transcriptional activity[J].Cancer Res,2006,66(24):11585-11589.
[13] Adam J,Karen J,Claire T,et al.WWOX:A candidate tumor suppressor gene involved in multiple tumor types[J].PNAS,2001,12(25):11417-11422.
[14] Xiao G,Fang H,Xing C,et al.Structure,function and inhibition of Bcl-2 family proteins:a new target for anti-tumor agents[J].Mini Rev Med Chem,2009,9(14):1596-1604.
[15] 雷 秦,王 娟.Bcl-2与Bcl-6在弥漫性大B细胞淋巴瘤中的表达及意义[J].现代检验医学杂志,2015,30(5):94-96.
Lei Q,Wang J.Expression and significance of Bcl-2 and Bcl-6 in diffuselarge B-cell lymphoma[J].Journal of Modern Laboratory Medicine,2015,30(5):94-96.
[16] Cory S,Huang CSD,Adams MJ.The Bcl-2 family:roles in cell survival and oncogenesis[J].Oncogene,2003,22(53):8590-8607.
[17] Ratajczak P,Leboeuf C,Wang L,et a1.BCL2 expression in CD105 positive cells and tumor progression in angioimmunoblastic T-cell lymphoma[J].Mod Pathol,2012,25(6):805-814.
[18] 兰会华,莫武宁,黄华艺.WWOX,P53及Bcl-2在鼻咽癌中的表达及意义[J].华中科技大学学报(医学版),2014,43(1):59-63.
Lan HH,Mo WN,Huang HY.Expression and implication of WWOX,p53 and Bcl-2 in nasopharyngeal carcinoma[J].Acta Medicinae Universitatis Scientiae Et Technologiae Huazhong(Medical Edition),2014,43(1):59-63.